COVID-19: ICU delirium management during SARS-CoV-2 pandemic-pharmacological considerations

Crit Care. 2020 Jun 23;24(1):375. doi: 10.1186/s13054-020-03072-5.

Authors

Lauren J Andrews¹, Scott T Benken²

Affiliations

¹ Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, 833 South Wood Street, RM 164 MC 886, Chicago, IL, 60612-7230, USA. [email protected].
² Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, 833 South Wood Street, RM 164 MC 886, Chicago, IL, 60612-7230, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections
Delirium*
Humans
Intensive Care Units
Pandemics
Pneumonia, Viral
SARS-CoV-2
Severe acute respiratory syndrome-related coronavirus*